EASO and ECPO issue joint warning regarding counterfeit obesity medicationsThe European Association for the Study of Obesity (EASO) and the European Coalition for People Living with Obesity (ECPO) have issued a...
Adverse effects of obesity medicationsResearchers from the University of Cincinnati’s James L Winkle College of Pharmacy have analysed the adverse events attributed to the use...
GLP-1s associated with higher risk of major depression, increased risk for anxiety and an elevated risk for suicidal behaviour1 day ago